Combination HIV Prevention, Linking Prevention and Care, for Hispanic Men

针对西班牙裔男性的艾滋病毒综合预防,将预防与护理联系起来

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Despite the existence of a government-led HIV prevention program focused on men who have sex with men and transgender women (MSM/TW) for nearly two decades in Peru, HIV incidence among them remains high at 5%, and most (70-75%) HIV+ MSM/TW are unaware of their HIV status. This is similar to the rest of Latin America, where sexual transmission among MSM/TW drives the HIV epidemic. HIV prevention efforts for MSM/TW in Peru are ineffective, in part, because this population remains exposed to high levels of societal discrimination, homophobia and transphobia, because of social norms favoring silence about HIV and sexual risk, and because of lack of cultural competent health services. Moreover, HIV+ MSM/TW face substantial HIV stigma, which affects disclosure of HIV status, willingness to obtain HIV testing and care, and social support. A multilevel intervention approach is needed that addresses factors at the individual, social/community, and health system levels, to facilitate earlier detection of HIV infection; linking, retaining, and re-engagin HIV+ people in care and treatment to achieve viral suppression; sexual risk reduction among both HIV- and HIV+ people; and community mobilization around these issues to provide support for and change social norms and engagement in HIV prevention and treatment. A multilevel approach stressing prevention-care links in the Continuum of Prevention and Care (CPC), is likely to reduce barriers to HIV prevention and care through integrated activities involving both community and health facilities, while creating synergy across the intervention elements. We have developed and piloted Proyecto Orgullo (PO), a multilevel, theory-based intervention that diffuses support for and creates positive social norms around HIV prevention by building a mobilized, empowered MSM/TW community to reduce unsafe sex and promote biannual HIV testing. PO has shown to be acceptable, feasible and potentially effective. In collaboration with the Peruvian Ministry of Health (MoH) and local healthcare facilities, we now propose to develop, implement and test the efficacy of PO+, an extension of PO that will facilitate full engagement in the CPC, and strengthen the linkage between the community and the health system. If shown effective, PO+ can be scaled up throughout Peru with the support of the MoH, and used as a model elsewhere in the Americas, including the US. The project aims are: (1) to create Proyecto Orgullo+ (PO+), a comprehensive, integrated, multilevel intervention that will focus on the CPC; (2) to implement PO+ for 3 years in Lima South, in collaboration with the Peruvian MoH, hospitals that provide HIV care, and HIV testing sites; (3) to evaluate the efficacy of PO+ in affecting the CPC by using: (a) data on the CPC, including sexual risk behavior, HIV testing frequency; incidence of anal Chlamydia and gonorrhea, and engagement in care among HIV+ people, collected through longitudinal cohorts of MSM/TW in Lima South and Lima East (the control area), recruited independently of the intervention, oversampling HIV+ MSM/TW; and (b) CD4 and VL data for HIV patients, collected and provided by the MoH.
 描述(由申请人提供):尽管在秘鲁,政府主导的艾滋病毒预防计划近二十年来一直专注于男男性行为者和变性妇女(MSM/TW),但他们中的艾滋病毒感染率仍然高达5%,大多数(70-75%)HIV+ MSM/TW不知道自己的艾滋病毒状况。这与拉丁美洲其他地区的情况类似,在那里,男男性行为者/第三世界妇女之间的性传播推动了艾滋病毒的流行。在秘鲁,针对男男性行为者/第三代妇女的艾滋病毒预防工作效果不佳,部分原因是这一人群仍然受到高度的社会歧视、仇视同性恋和仇视变性人,社会规范倾向于对艾滋病毒和性风险保持沉默,以及缺乏文化上合格的保健服务。此外,HIV+ MSM/TW面临严重的艾滋病毒污名,这影响了艾滋病毒状况的披露,获得艾滋病毒检测和护理的意愿以及社会支持。需要采取多层次的干预办法,解决个人、社会/社区和卫生系统层面的因素,以促进及早发现艾滋病毒感染;在艾滋病毒阳性者中建立联系、留住和重新安置,以实现病毒抑制;减少艾滋病毒阳性者和艾滋病毒阳性者的性风险;并围绕这些问题进行社区动员,为艾滋病毒预防和治疗提供支持和改变社会规范和参与。一个多层次的方法,强调预防和护理的连续体(CPC)的预防-护理的联系,有可能减少艾滋病毒的预防和护理的障碍,通过综合活动,涉及社区和卫生设施,同时创造跨干预要素的协同作用。我们制定并试行了Orgullo项目(PO),这是一个多层次的、以理论为基础的干预措施,通过建立一个动员起来的、有能力的MSM/TW社区,减少不安全性行为,促进一年两次的艾滋病毒检测,传播对艾滋病毒预防的支持,并建立积极的社会规范。PO已被证明是可接受的,可行的和潜在的有效性。在与秘鲁卫生部(MoH)和当地医疗机构的合作下,我们现在建议开发,实施和测试PO+的有效性,PO+是PO的延伸,将促进全面参与CPC,并加强社区和卫生系统之间的联系。如果证明有效,PO+可以在卫生部的支持下在整个秘鲁推广,并作为包括美国在内的美洲其他地区的典范。 该项目的目标是:(1)创建项目Orgullo+(PO+),这是一个全面、综合、多层次的干预措施,将重点放在CPC上;(2)与秘鲁卫生部、提供艾滋病毒护理的医院和艾滋病毒检测站合作,在利马南部实施PO+3年;(3)通过使用以下方法评估PO+影响CPC的效果:(a)通过利马南部和利马东部的男男性行为者/第三世界纵向队列收集的关于CPC的数据,包括性风险行为、艾滋病毒检测频率、肛门衣原体和淋病发病率以及艾滋病毒阳性者的护理参与情况(对照区),独立于干预措施招募,对HIV+ MSM/TW进行过采样;(B)由卫生部收集和提供的HIV患者的CD 4和VL数据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carlos F. Caceres其他文献

Evaluation of a minimal array of emTreponema pallidum/em antigens as biomarkers for syphilis diagnosis, infection staging, and response to treatment
评估一个最小的梅毒螺旋体抗原阵列作为梅毒诊断、感染分期和治疗反应的生物标志物
  • DOI:
    10.1128/spectrum.03466-23
  • 发表时间:
    2023-12-05
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Austin M. Haynes;Kelika A. Konda;Emily Romeis;Janet Siebert;Silver K. Vargas;Michael Reyes Diaz;Amber Phan;Carlos F. Caceres;Lorenzo Giacani;Jeffrey D. Klausner;Cecilia M. Thompson
  • 通讯作者:
    Cecilia M. Thompson
Correction to: Brief intervention to prevent HIV, STI and unintended pregnancies: preliminary results of a feasibility study from the perspective of healthcare providers in Peru
  • DOI:
    10.1186/s12913-021-07417-w
  • 发表时间:
    2021-12-01
  • 期刊:
  • 影响因子:
    3.000
  • 作者:
    Jean Pierre Jiron;Clara Sandoval;Juan Carlos Enciso;Ana Sofía De Vasconcelos;Karel Blondeel;Nataliia Bakunina;Galina Lesco;Igor Toskin;Rob Stephenson;Carlos F. Caceres
  • 通讯作者:
    Carlos F. Caceres
Correction to: HIV Risk Perception and Pre-Exposure Prophylaxis (PrEP) Awareness Among Transgender Women from Mexico
  • DOI:
    10.1007/s10461-022-03887-z
  • 发表时间:
    2022-11-08
  • 期刊:
  • 影响因子:
    2.400
  • 作者:
    Centli Guillen-Diaz-Barriga;Dulce Diaz-Sosa;Thiago S. Torres;Kelika A. Konda;Rebeca Robles-Garcia;Brenda Hoagland;Marcos Benedetti;Cristina Pimenta;Beatriz Grinsztejn;Carlos F. Caceres;Valdilea G. Veloso;Hamid Vega-Ramirez
  • 通讯作者:
    Hamid Vega-Ramirez
Baseline variables associated with subsequent HIV seroconversion among gay, bisexual and other men who have sex with men and transgender women: a prospective, multicenter PrEP demonstration study (ImPrEP)
男同性恋、双性恋及其他男男性行为者和跨性别女性中与后续艾滋病病毒血清转化相关的基线变量:一项前瞻性、多中心暴露前预防示范研究(ImPrEP)
  • DOI:
    10.1016/j.lana.2025.101098
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    7.600
  • 作者:
    Carlos F. Caceres;Heather Pines;Kelika A. Konda;Annick Borquez;Ronaldo Moreira;Iuri Leite;Pedro Amparo;Marcelo Cunha;Thiago S. Torres;Juan V. Guanira;Jean-Pierre Jirón;Brenda Hoagland;Heleen Vermandere;Marcos Benedetti;Hamid Vega;Carlos M. Benites;Cristina Pimenta;Beatriz Grinztejn;Valdiléa Veloso;J. David Urbaez-Brito;Karen Campos
  • 通讯作者:
    Karen Campos
Laboratory evaluation of oral fluid for syphilis screening among clinic users from Lima, Peru
秘鲁利马门诊患者口腔液用于梅毒筛查的实验室评估
  • DOI:
    10.1128/spectrum.01298-24
  • 发表时间:
    2024-12-06
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Jazmin Qquellon;Silver K. Vargas;Francesca Vasquez;E. Michael Reyes-Diaz;Kelika A. Konda;Carlos F. Caceres;Jeffrey D. Klausner
  • 通讯作者:
    Jeffrey D. Klausner

Carlos F. Caceres的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carlos F. Caceres', 18)}}的其他基金

Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design
梅毒免疫学和生物学改善临床管理和疫苗设计
  • 批准号:
    10392824
  • 财政年份:
    2018
  • 资助金额:
    $ 57.1万
  • 项目类别:
Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design
梅毒免疫学和生物学改善临床管理和疫苗设计
  • 批准号:
    10239030
  • 财政年份:
    2018
  • 资助金额:
    $ 57.1万
  • 项目类别:
Combination HIV Prevention, Linking Prevention and Care, for Hispanic Men
针对西班牙裔男性的艾滋病毒综合预防,将预防与护理联系起来
  • 批准号:
    9228394
  • 财政年份:
    2016
  • 资助金额:
    $ 57.1万
  • 项目类别:
DEVELOPING A STATE-OF-THE-ART COMBINATION HIV PREVENTION PROGRAM FOR MSM/TRANSWOM
为 MSM/TRANSWOM 制定最先进的 HIV 联合预防计划
  • 批准号:
    8603393
  • 财政年份:
    2013
  • 资助金额:
    $ 57.1万
  • 项目类别:
Planning a Strategic HIV Population Science Training Grant in Peru
规划秘鲁艾滋病毒人口科学战略培训补助金
  • 批准号:
    8516318
  • 财政年份:
    2013
  • 资助金额:
    $ 57.1万
  • 项目类别:
DEVELOPING A STATE-OF-THE-ART COMBINATION HIV PREVENTION PROGRAM FOR MSM/TRANSWOM
为 MSM/TRANSWOM 制定最先进的 HIV 联合预防计划
  • 批准号:
    8733757
  • 财政年份:
    2013
  • 资助金额:
    $ 57.1万
  • 项目类别:
Planning a Strategic HIV Population Science Training Grant in Peru
规划秘鲁艾滋病毒人口科学战略培训补助金
  • 批准号:
    8709014
  • 财政年份:
    2013
  • 资助金额:
    $ 57.1万
  • 项目类别:
Syphilis: Translating technology to understand a neglected epidemic
梅毒:利用技术来了解一种被忽视的流行病
  • 批准号:
    9124707
  • 财政年份:
    2012
  • 资助金额:
    $ 57.1万
  • 项目类别:
Syphilis: Translating technology to understand a neglected epidemic
梅毒:利用技术来了解一种被忽视的流行病
  • 批准号:
    8906723
  • 财政年份:
    2012
  • 资助金额:
    $ 57.1万
  • 项目类别:
Syphilis: Translating technology to understand a neglected epidemic
梅毒:利用技术来了解一种被忽视的流行病
  • 批准号:
    8515276
  • 财政年份:
    2012
  • 资助金额:
    $ 57.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了